The Rheumatologist
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
  • Technology
    • Electronic Health Records
    • Apps
    • Information Technology
  • Resources
    • Issue Archives
    • Events
    • Multimedia
      • Audio
      • Video
    • From the College
    • American College of Rheumatology
    • Rheumatology Research Foundation
    • Arthritis & Rheumatology
    • Arthritis Care & Research
    • Treatment Guidelines
    • Research Reviews
    • Annual Meeting
      • Abstracts
      • Meeting Reports
    • Rheumatology Image Bank
    • ACR ExamRheum
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Drug Commercials—How Are They Still a Thing?

Drug Commercials—How Are They Still a Thing?

July 19, 2018 • By Philip Seo

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Tero Vesalainen / shutterstock.com

Tero Vesalainen / shutterstock.com

Picture this: It’s 3 o’clock in the morning. You can’t sleep. You settle in front of the television to watch a rerun of Dirty Dancing. And then it hits you: Ask your doctor.

You Might Also Like
  • U.S. Doctor Group Calls for Ban on Drug Advertising to Consumers
  • Pharma awaits FDA Guidance to Navigate the Murky Waters of Ads Via the Internet and Social Media
  • Aetna, Seeking Antitrust Nod, Sells Medicare Drug Business to WellCare
Explore This Issue
July 2018
Also By This Author
  • The First Step: Pay Equity in Medicine

Even as your eyelids sag, some part of your primitive forebrain snaps to attention. Medical training has turned us all into multitaskers, and even as some part of you is desperately trying to fall asleep, another part of your brain has just woken up.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Then you hear it: Not to be used if you have a history of myocardial infarction or stroke. Some patients may experience a paradoxical worsening in their symptoms. Use with caution if you have a history of major depressive disorder or bipolar disorder.

Then the refrain hits: Ask your doctor.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Then you see it: Happy people, laughing at a picnic, on the beach or at a touch football game, with sunlight streaming down. Meaningful looks are exchanged. More smiles ensue. Clearly, something good is happening here, but what?

That is a little harder to discern, because you only started paying attention to the commercial when the anonymous announcer started to rattle off, in rapid succession, all of the medical diagnoses and issues that stand between you and that happy ending. If only you could take this pill, happiness could be yours.

John Oliver, host of the eponymous show on HBO, has an intermittent feature that he calls “How Is This Still a Thing?” He uses this feature to focus on anachronisms or oddities of American culture that persist, despite our inclination to think of ourselves as enlightened. Daylight saving time, which causes us to gain, and then lose, an hour of sleep every year. The penny, which serves to provide commerce with a level of precision that nobody wants. Columbus Day, which celebrates the man who did not discover America.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

How Is This Still a Thing?

That catchphrase leaps to my mind every time I see a commercial for a drug on network television. Before my publishing overlords get too worked up, let me mention that I am not objecting to pharmaceutical advertising that targets physicians, such as the ads that appear throughout these pages. Outside my personal gratitude for their support, which enables this publication to exist, this sort of targeted advertising makes sense to me. Not only are these drugs directly relevant to my practice, I also have the ability to understand what the ad means, beyond the glossy pictures of antibodies and glorious sunsets.

Pages: 1 2 3 4 5 | Single Page

Filed Under: Rheuminations Tagged With: patient communication, patient managementIssue: July 2018

You Might Also Like:
  • U.S. Doctor Group Calls for Ban on Drug Advertising to Consumers
  • Pharma awaits FDA Guidance to Navigate the Murky Waters of Ads Via the Internet and Social Media
  • Aetna, Seeking Antitrust Nod, Sells Medicare Drug Business to WellCare
  • Medicare Drug Coverage Plans for Rheumatologic Medications

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR/ARP Annual Meeting

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Annual Meeting site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2019 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.